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Abstract
Objective—Reactive oxygen species (ROS) act as signaling molecules during angiogenesis,
however, the mechanisms used for such signaling events remain unclear. Stromal cell-derived
factor-1α (SDF-1α) is one of the most potent angiogenic chemokines. Here we examined the role
of ROS in the regulation of SDF-1α-dependent angiogenesis.
Approach and results—Bovine aortic endothelial cells (BAECs) were treated with SDF-1α
and intracellular ROS generation was monitored. SDF-1α treatment induced BAEC migration and
ROS generation, with the majority of ROS generated by BAECs at the leading edge of the
migratory cells. Antioxidants and NADPH oxidase (NOX) inhibitors blocked SDF-1α-induced
endothelial migration. Furthermore, knockdown of either NOX5 or p22phox (a requisite subunit
for NOX1/2/4 activation) significantly impaired endothelial motility and tube formation,
suggesting that multiple NOXs regulate SDF-1α-dependent angiogenesis. Our previous study
demonstrated that JNK3 activity is essential for SDF-1α-dependent angiogenesis. Here, we
identified that NOX5 is the dominant NOX required for SDF-1α-induced JNK3 activation and that
NOX5 and MKP7 (the JNK3 phosphatase) associate with one another but decrease this interaction
upon SDF-1α treatment. Furthermore, MKP7 activity was inhibited by SDF-1α and this inhibition
was relieved by NOX5 knockdown, indicating that NOX5 promotes JNK3 activation by blocking
MKP7 activity.
Conclusions—We conclude that NOX is required for SDF-1α signaling and that intracellular
redox balance is critical for SDF-1α-induced endothelial migration and angiogenesis.
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Reactive oxygen species (ROS) are generated not only as by-products of mitochondrial
metabolism, but also by a variety of cellular enzyme systems including NADPH oxidase
(NOX), uncoupled endothelial nitric oxide synthase (eNOS), xanthine oxidase and
arachidonic acid metabolizing enzymes. When cellular production of ROS exceeds the
antioxidant capacity of cardiovascular cells, proteins, lipids and nucleic acids become
damaged and may eventually contribute to the development of cardiovascular diseases such
as atherosclerosis, hypertension, diabetic cardiovascular complications and ischemic-
reperfusion injury. Conversely, low concentrations of ROS play a critical role in regulating
cardiovascular functions such as angiogenesis and tissue repair.1–3 ROS are required for
VEGF-induced endothelial migration, proliferation and tube formation.4, 5 During ischemia
and reperfusion, ROS generation promotes capillary tube formation in human microvascular
endothelial cells6 and the heart7, whereas inhibiting ROS through treatment with
antioxidants or superoxide dismutases blocks vascularization and growth of tumors.8, 9 The
precise molecular mechanisms, however, by which ROS mediate angiogenic responses are
incompletely understood.
NOX is an important enzymatic source of ROS. There are seven Nox genes identified in
mammalian organisms - Nox1-5 and Duox (Dual Oxidase) 1–2. NOXs are expressed in
endothelial cells and other cardiovascular cells and regulate various functions such as cell
survival, growth, apoptosis, differentiation, angiogenesis and contractility.10 The NOX
enzymes are heteroprotein complexes (except NOX5) with different regulatory mechanisms,
tissue distribution and subcellular localization and downstream targets. A membrane
regulatory subunit, p22phox, is associated with NOXs 1, 2 and 4, and is required for their
activity.10 NOXs 1 and 2 share a common overall structure with a very short cytoplasmic N-
terminus, that is required for activation11–13, and six transmembrane domains.14, 15 In
contrast, NOX4 is constitutively active and is regulated by gene expression.16 Interestingly,
unlike other NOXs, NOX5 possesses a longer cytoplasmic N-terminus containing Ca2+-
binding motifs, resulting in its activation by Ca2+ elevation.17 ROS generated by NOXs 1, 2
and 4 mediate angiogenic effects in response to angiogenic factors such as VEGF and
angiotensin II.10 However, the exact function of these NOXs and the underlying
mechanisms by which they mediate their actions remain unknown, partly due to inconsistent
published observations and context-dependent efficacy.
Stromal cell-derived factor 1α (SDF-1α, also called CXCL12) is one of the most potent
angiogenic CXC chemokines. Our previous studies have shown that SDF-1α requires MKP7
S-nitrosylation to activate JNK3 and promote endothelial migration and angiogenesis.18
MKP7 belongs to a subgroup of protein tyrosine phosphatases (PTPs), which are widely
recognized as targets of ROS that can be oxidized at redox-sensitive cysteine residues
resulting in the inhibition of phosphatase activity following growth factor treatment.19–21
MKP7 possesses a critical cysteine in its catalytic pocket that is highly sensitive to oxidation
due to its low pKa.22 Therefore, we hypothesized that NOX-generated ROS may oxidize
and inhibit MKP7, thereby regulating SDF-1α-dependent JNK3 activity and angiogenesis.
By performing a series of biochemical and cell biological assays, we have developed strong
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evidence that suggests that NOXs, including NOX5, are novel positive regulators of
SDF-1α-induced endothelial migration and angiogenesis.
MATERIAL AND METHODS
Materials and Methods are available in the online-only supplement.
RESULTS
SDF-1α induces transient generation of ROS in BAECs
Our previous studies demonstrated that MKP7 S-nitrosylation and subsequent inhibition is
required for SDF-1α-induced endothelial migration and angiogenesis.18 MKP7 activity can
also be modified and inhibited through oxidation of a critical redox sensitive cysteine in its
catalytic pocket.22 NOXs 1, 2 and 4 are the major source of ROS in endothelial cells.23. In
addition, they regulate angiogenesis in response to growth factors such as VEGF and
angiotensin II.10 However, the exact function of these NOXs remain elusive and whether
NOX-generated ROS regulate SDF-1α-dependent signaling is unknown. We hypothesized
that NOX-generated ROS may be another mechanism by which MKP7 activity is inhibited
during SDF-1α-dependent angiogenesis. To investigate the role of NOX-generated ROS in
SDF-1α-dependent angiogenesis, we first examined ROS generation in BAECs following
SDF-1α treatment. The fluorescent dyes CM-H2DCFDA and dihydroethidium (DHE) were
used to monitor and determine the level of hydrogen peroxide (H2O2) and superoxide (O2·−)
production, respectively, in BAECs following treatment with SDF-1α. When cells were
treated with SDF-1α for 5 minutes, an increase in fluorescent DCF signal was detected in
BAECs by confocal microscopy (Figure 1A) and by flow cytometry (from 0.01% cells
positive under control conditions to 15.45% cells in response to SDF-1α; Figure 1B & SIA).
Moreover, this SDF-1α-induced DCF signal was inhibited by PEG-catalase, but not the
inhibitors of nitric oxide synthase (NOS)- L-NAME and that of cyclooxygenase-diclofenac
(Figure SIB, C, D and E), suggesting that this detected DCF signal is due to H2O2
generation, but not the formation of peroxynitrites or arachidonate metabolites. SDF-1α
treatment of BAECs also resulted in O2·− generation, detected by the appearance of
fluorescent ethidium generated from oxidation of DHE. SDF-1α-induced superoxide
production rapidly increased ~2 fold, peaking at 5-minutes after the SDF-1α treatment
began (Figure 1C). Moreover, the superoxide level was induced in a dose- dependent
manner (Figure 1D). To determine whether ROS were generated during SDF-1α -induced
endothelial cell migration, a wound scratch assay was performed to visualize the active
migratory process of BAECs following SDF-1α treatment. Consistent with the observations
above, SDF-1α treatment of BAECs resulted in generation of a fluorescent DCF signal that
was most prominent at the leading edge of the BAECs where active migration takes place
(Figure 1E). These data suggest that ROS are generated in response to SDF-1α treatment in
BAECs and that this ROS generation correlates with the SDF-1α-dependent migratory
response.
Pi et al. Page 3






















Antioxidants inhibit SDF-1α-induced JNK3 activation and endothelial migration
To determine whether the ROS generation seen at the leading edge of the migrating BAECs
is necessary for SDF-1α-induced migration, the wound scratch assay was repeated in the
presence of the two antioxidants NAC and ebselen. As shown in Figure 2A, SDF-1α-
induced BAEC migration was significantly inhibited by pretreatment of cells with either
NAC or ebselen, indicating that ROS generation is required for SDF-1α-induced cell
migration.
NOXs is required for SDF-1α-induced angiogenesis
Recent evidence indicates that NOXs are the major sources of ROS in endothelial cells.23
Given our observation that SDF-1α treatment of BAECs resulted in ROS generation that
was associated with SDF-1α-induced cell migration, we next examined whether NOXs were
also involved in these events. Using the Boyden chamber migration assay, we observed that
SDF-1α treatment increased BAEC migration from 13±1 to 48±1 cells per field (Figure 2B),
but that SDF-1α-induced migration could be completely inhibited by the two general NOX
inhibitors DPI and apocynin (Figure 2B), indicating that NOX enzyme-dependent ROS
generation is essential for SDF-1α-mediated BAEC migration.
Four different NOX enzymes (NOX1, 2, 4 and 5) are expressed in vascular endothelial cells
such as BAECs (Figure SIIA).10 NOX 1, 2 and 4 have each been linked to angiogenic
responses, however, the underlying molecular mechanisms behind these events are not
completely understood. Furthermore, since previous experiments have been largely
performed in rodent cells, which do not express NOX5, the role for NOX5 in angiogenesis
has yet to be determined. Therefore, to determine which NOX was responsible for SDF-1α-
induced angiogenesis, we first examined the effect of knockdown of NOX5 or p22phox, a
crucial component of NOX1/2/4 active enzyme complexes10, on SDF-1α-induced
endothelial migration in BAECs. p22phox or NOX5 siRNA specifically decreased the RNA
and protein levels of p22phox or NOX5 respectively, but not other NOXs in BAECs (Figure
SIIB, C). Similar to antioxidants or NOX inhibitors, knockdown of either NOX5 or p22phox
decreased superoxide generation (Figure SIID). More excitingly, their knockdown blocked
endothelial migration induced by SDF-1α (Figure 2C), suggesting that multiple NOXs,
including NOX5, are involved in SDF-1α-induced endothelial migration. To assess the
effect of NOX depletion on tube formation, BAECs were transfected with siRNA specific
for either NOX5 or p22phox and the effect on SDF-1α-induced tube formation in Matrigel
was analyzed. 72 hours following transfection with p22phox siRNA, NOX5 siRNA or
control siRNA, BAECs cells were plated on Matrigel in medium containing 100 ng/ml
SDF-1α. SDF-1α treatment significantly enhanced tube formation in BAECs transfected
with control siRNA, with the tube number increasing from 12±3 to 68±10 tubes per field
(Figure 2D). In contrast, SDF-1α-induced tube formation was significantly blocked in
BAECs transfected with either p22phox siRNA or NOX5 siRNA, by 4.5- or 3.4-fold
respectively (Figure 2D). To confirm this anti-angiogenic effect of p22phox and NOX5
siRNAs, we also performed a spheroid-sprouting angiogenesis assay using BAECs treated
with SDF-1α. This assay measures the sprouting and network formation of gel-embedded
aggregated endothelial cells. Endothelial spheroids were prepared with BAECs transfected
with different siRNAs and then stimulated with SDF-1α. The total number of sprouts from
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each spheroid was counted and compared with control cells. As shown in Figure SIIE,
SDF-1α-treated BAECs showed a 3.4-fold increase in sprouts/spheroids when compared
with control BAECs. However, this increase in SDF-1α-induced sprout formation was
inhibited in BAECs transfected with either p22phox or NOX5 siRNA. The data collected
from the Matrigel and spheroid-sprouting angiogenesis assays strongly suggest that multiple
NOXs, including NOX5 and probably NOX1/2/4, are critical mediators of SDF-1α-
dependent angiogenesis in BAECs.
NOX5, but not NOX1/2/4, is required for JNK3 activation induced by SDF-1α
We have previously demonstrated that JNK3 is an important component of SDF-1α-
mediated endothelial migration and angiogenesis18. Since the data above demonstrates that
NOX-generated ROS also play an essential role in SDF-1α-dependent angiogenesis (Figure
2), we tested whether SDF-1α-induced JNK3 activation was influenced by NOX-dependent
ROS generation. All three antioxidants- BHA, NAC and ebselen- inhibited SDF-1α-induced
JNK phosphorylation in BAECs (Figure 3A and SIIIA). SDF-1α-induced JNK3 activation
was also inhibited by the NOX inhibitors DPI and apocynin (Figure 3B). To test which
NOX isoform was involved in SDF-1α-induced JNK3 activation, BAECs were transfected
with p22phox siRNA, NOX5 siRNA or control siRNA. Activation of SDF- 1α-induced
JNK3 activation was dramatically decreased by knockdown of NOX5, but not by
knockdown of p22phox (Figure 3C). Furthermore, ectopic expression of NOX5 in BAECs
was sufficient to activate JNK3 at baseline and augmented JNK3 activation following
SDF-1α stimulation (Figure 3D). The inhibitory effect of NOX inhibitors and NOX5
siRNAs on SDF-1α-induced JNK3 activation was further confirmed in human vascular
endothelial cells (HUVECs; Figure SIIIB, C and D). Moreover, we also observed that ERK
activation in response to SDF-1α was also blocked by NOX inhibitors and NOX5 siRNAs,
but not p22phox siRNAs in both BAECs and HUVECs (Figure SIIIC, E and F). In
summary, these data suggest that NOX5, but not NOX1/2/4, is required and sufficient for
SDF-1α-induced JNK3 and ERK activation. In addition to the effects seen by SDF-1α, we
also observed other cytokines, including TNF1α and interleukin 1β (IL1β), but not bFGF,
evoke an increase in superoxide generation in BAECs (Figure SIVA, B and C).
Furthermore, the activation of JNK by TNF1α was inhibited by NOX5 siRNA, but not
p22phox siRNA (Figure SIVD). The activation of NOX1, 2 and 4 and ROS generation
regulate VEGF-induced angiogenesis24. However, the involvement of NOX5 has not been
tested. To assess the effect of NOX5 depletion on VEGF-induced tube formation, HUVECs
were transfected with NOX5 siRNA. VEGF increased the formed tube number in control
cells. However, the knockdown of NOX5 inhibited tube formation in response to VEGF
significantly (Figure SIVE, F). Taken together, we speculate that the NOX5-dependent
signaling pathway may represent a relatively general mechanism for growth factors and
cytokines.
ROS induce the expression of numerous genes including those that code for antioxidant
proteins. One such antioxidants, heme oxygenase-1 (HO-1) has previously been linked to
SDF-1 induced angiogenesis25. Therefore, we were interested to test whether HO-1
expression in BAECs is also regulated by NOXs. Excitingly, when BAECs were treated
with SDF-1α for 8 hours, the protein level of HO-1 increased dramatically, which is
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consistent with a previous report25. However, the induction in HO-1 protein level was
inhibited in cells that were transfected with NOX5 siRNAs, but not p22phox siRNAs
(Figure SV), indicating that HO-1 is likely one of the downstream mediators for NOX5’s
angiogenic effect in BAECs.
Hyperglycemia disrupts SDF-1α-dependent ROS generation and JNK3 activation
Increased oxidative stress is associated with many chronic diseases, including diabetes and
related cardiovascular diseases26. SDF-1α is a dominant angiogenic factor in multiple
pathological conditions such as diabetic retinopathy27. Therefore, we investigated the effect
of elevated ROS level on SDF-1α-dependent signaling when BAECs were cultured under
elevated glucose conditions. Comparing the cells cultured under normal glucose
concentration (7 mM glucose), the incubation of cells with ~3.3-fold higher glucose level for
three days significantly increased the intracellular ROS level (Figure 4A). Reports have
demonstrated that NOX1/2/4, but not NOX5, are responsible for the elevation of ROS level
in response to high glucose in vascular cells26, 28, 29. Interestingly, when cells were cultured
under normal glucose concentrations, SDF-1α increased JNK3 activation and antioxidant-
ebselen blocked it. However, when cells were cultured with a higher concentration of
glucose, the response of JNK3 activation to SDF- 1α was blunted (Figure 4B). Together,
these data suggest that SDF-1α-dependent NOX5 activation and its downstream signaling
are inhibited under hyperglycemic conditions and that the regulatory roles of NOX1/2/4 and
NOX5 are likely altered when cellular glucose homeostasis is disrupted.
NOX5 is associated with MKP7 in BAECs and inhibits MKP7 activity
The preceding experiments indicate that NOX5 is the dominant NOX responsible for
SDF-1α-induced JNK3 activation. However, the molecular mechanisms underlying this
NOX5-dependent signaling event are not clear. S-nitrosylation of the catalytic cysteine of
MKP7, which blocks its phosphatase activity, is required for the SDF-1α-induced activation
of JNK3.18 Interestingly, the labile cysteine at the catalytic center of MKPs is also
susceptible to oxidation.22 Indeed, oxidation of this cysteine by TNFα-generated ROS is
critical for activation of JNK1 and the apoptotic effects of TNFα.22 This prompted us to
examine whether ROS, generated by NOX5 could result in oxidation of MKP7. In order for
NOX5-generated ROS to efficiently oxidize MKP7, NOX5 and MKP7 would need to be in
close proximity30. To determine the relative localization of MKP7 and NOX5, Flag-tagged
MKP7 and GFP-tagged NOX5 were transfected into BAECs and their localization
determined using confocal microscopy. Both flag-tagged MKP7 (Figure 5B) and GFP-
tagged NOX5 co-localized to the plasma membrane and cytoplasm of BAECs (Figure 5A),
indicating a spatial proximity that would be favorable for NOX5 oxidation of MKP7. To
determine whether these two proteins associate directly, immunoprecipitation assays were
performed on transfected cells. As shown in Figure 5C, Flag-tagged MKP7 was detected in
a protein complex immunoprecipitated with Myctagged NOX5 but not Myc-p22phox,
suggesting that MKP7 was associated with NOX5 specifically in HEK 293 cells. The
reverse co-immunoprecipitation experiment confirmed the association of MKP7 with NOX5
(Figure SVIA). Co-immunoprecipitation of endogenous MKP7 and NOX5 from BAECs
confirmed that, under basal conditions, MKP7 and NOX5 were associated together (Figure
5D). However, following SDF-1α treatment, the proteins dissociated, suggesting a possible
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mechanism for reversible SDF-1α regulation of MKP7 (Figure 5D, E). To identify which
region of MKP7 was responsible for NOX5 binding, a series of MKP7 deletion mutants
(Figure 5B) were engineered. Using co-immunoprecipitation experiments once again, we
determined that MKP7 (318–665) but not MKP7 (1–317) was associated with NOX5
(Figure SVIB). Further mutations of the 318–665 fragment revealed that MKP7 (415–440;
indicated by black arrow in Figure 5B) was required for association with NOX5 (Figure 5F).
Taken together, these data demonstrate that MKP7 and NOX5 associate in BAECs and that
this association is dynamically regulated by SDF-1α.
Having established that NOX5 and MKP7 do associate with one another in BAECs, we next
sought to determine whether ROS generated from SDF-1α-induced activation of NOX5
oxidizes MKP7, resulting in the inhibition of MKP7 phosphatase activity and subsequent
activation of JNK3. An in vitro MKP7 activity analysis was performed using active JNK3
protein and MKP7 concentrated from cell lysates following our established protocol18. At
baseline, Flag-tagged MKP7 protein demonstrated strong phosphatase activity as shown by
the decrease in JNK3 phosphorylation (Figure 6A). Similar to our previous report18, the
treatment of SDF-1α blocked 42.8% of MKP7 phosphatase activity (Figure 6A and B).
However, when cells were treated with the NOX inhibitor DPI, MKP7 retained high
phosphatase activity at both baseline and following SDF-1α-treatment of cells (Figure 6A
and B). Similarly, NOX5 knockdown via transfection of cells with NOX5 specific siRNAs
relieved the inhibitory effect of SDF-1α on MKP7 phosphatase activity (Figure 6C and D).
These data suggest that ROS generated by NOX5 inhibits MKP7 phosphatase activity,
offering one plausible mechanism by which NOX5 promotes SDF-1α-induced JNK3
activation.
Our previous study has demonstrated that MKP7 can be nitrosylated by nitric oxide
generated by eNOS after eNOS is activated in response to SDF-1α treatment.18 Similar to
eNOS activation leads to the inhibition of MKP7 phosphatase activity18, NOX5 activation
blocked MKP7 activity and enhanced JNK3 activation. Therefore, we tested whether the
blockage of both eNOS and NOX5 activities would result in synergistic inhibitory effects on
JNK3 activation. BAECs were transfected with both siRNAs of eNOS and NOX5 and the
changes of JNK3 activity were determined. Interestingly, the knockdown of NOX5 or eNOS
blocked the activation of JNK3. However, the knockdown of both NOX5 and eNOS did not
further significantly inhibit the activation of JNK3 (Figure SVII). It suggests that NOX5 and
eNOS might work on the same pathway upstream of JNK3 activation. Reports have shown
that NOX5 induces eNOS activity possibly by enhancing eNOS:hsp90 binding or increasing
intracellular calcium level31. Another regulatory mechanism for their interaction could be
that both eNOS and NOX5 regulate MKP7 activation.
Taken all together, our data identify NOX5 as a novel component of SDF-1α-dependent
JNK3 activation and support the hypothesis that NOX-generated ROS are important
mediators of SDF-1α-dependent angiogenesis. More importantly, both nitrous and oxidative
stresses, and therefore the intracellular redox status, are important for SDF-1α- dependent
signaling and endothelial activation in response to pathophysiologic conditions such as
hyperglycemia.
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NOXs are well accepted as being as novel players in the regulation of angiogenesis.
However, the underlying mechanisms by which they exert their actions have not been
completely elucidated. Using NOX inhibitors and NOX5-specific siRNA, we have
demonstrated a requisite role for NOX5 in the regulation of SDF-1α-dependent JNK3
activation, and subsequent endothelial activation and angiogenesis. This is the first report
demonstrating that NOX-generated ROS are required for the angiogenic effects of SDF-1α
in endothelial cells. Moreover, we observed that multiple cytokines including SDF-1α,
TNF1α and IL1β induced superoxide generation and the activation of JNK by TNF1α was
inhibited by NOX5 siRNA (Figure SIV). This recapitulates previous evidence demonstrating
that NOX-generated ROS play an important role in angiogenic signaling in response to
growth factors and cytokines.10 Given the lack of NOX5 expression in rodents, the
functional roles of NOX5 have not been well studied. However, our data hints at an
unexpected role for NOX5 in the regulation of human pathophysiology that is associated
with angiogenesis.
Increased oxidative stress is associated with many chronic diseases, including diabetes and
related cardiovascular diseases26. Our observation that SDF-1α-dependent JNK3 activation
was blunted under hyperglycemic conditions (Figure 4) indicates that NOX-dependent ROS
generation normally required for angiogenesis is dysregulated in a microenvironment where
significantly higher levels of oxidative stress are present. Therefore, both beneficial and
detrimental roles of ROS, whose generation might be due to the activation of different
enzyme and non-enzyme systems, on endothelial pathophysiology need further clarification
to improve the efficacy and safety of therapeutic strategies involving use of antioxidants and
NOX inhibitors. In addition, NOX5 is up-regulated in some cancers, such as prostate cancer,
esophageal adenocarcinoma and hairy cell leukemia.32–34 DPI, a general NOX inhibitor,
potently inhibits the migration, proliferation and invasion of prostate cancer cells by
modulating the activity of growth signaling pathways including ERK1/2, p38 and causing
cell cycle arrest.35 Based on our finding that NOX-generated ROS participate in angiogenic
events, it is also possible that DPI blocks angiogenesis within the tumor, thereby increasing
its usefulness as an anti-tumor therapy. Likewise, blockade of the SDF-1α/CXCR4 signaling
axis, including NOX5, may represent a promising additional or alternative target for the
treatment of some forms of cancer such as rectal carcinoma and colorectal cancer in which
SDF-1α levels are seen to increase following reoccurrance of tumors after chemo- and anti-
VEGF therapy36, 37. Targeting NOX5 in the SDF-1α pathway may also be useful in
treatment against atherosclerosis. In the vascular system, NOX5 is predominantly expressed
in endothelial cells, but is also detected in smooth muscle cells. In atherosclerotic aortas, the
expression level of endothelial NOX5 is increased38. Given our data demonstrating that
NOX5 is involved in angiogenic responses in endothelial cells, it is quite possible that the
elevation in NOX5 expression in atherosclerotic lesions exacerbates plaque formation by
promoting new vessel formation. Blockade of NOX5 may therefore be one mechanism by
which the development of atherosclerotic plaques can be cured.
The data presented in this report is the first demonstration that NOXs are activated by the
SDF-1α/CXCR4 signaling axis. All forms of NOX (NOX 1, 2, 4 and 5) are expressed in
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endothelial cells.10 Previous studies have demonstrated that p22phox is required for activity
of NOX1, NOX2 and NOX4.10 Since knockdown of p22phox also blocked SDF- 1α-
induced endothelial migration and angiogenesis, we conclude that NOX1, NOX2 and/or
NOX4, in addition to NOX5, can be activated by SDF-1α in endothelial cells. That said,
their activation and downstream effectors are very likely to be different based on their
individual molecular structures. NOX5 possesses additional cytosolic N-terminal EF-hands
for binding calcium, rendering it able to be activated by calcium, probably due to the fact
that the binding of calcium to these EF-hands relieves the auto-inhibitory loop on the
activity domain of NOX5.39 CXCR4, a G-protein coupled receptor, is ligated by SDF-1α
and it activation initiates a series of signaling processes including an increase in calcium
influx.40 Alternative calcium-independent mechanisms have also been reported to promote
calcium sensitization and activation of NOX5.39 Whether calcium influx or other
mechanisms of calcium sensitization is required for NOX5 activation by SDF-1α remains to
be determined. In contrast to NOX5, the activation of NOX1, NOX2 and NOX4 are
regulated differentially by small G proteins and multiple kinases. Rac GTPases are required
for both NOX1 and NOX2 activity.41–44 PKC, PI3K and Src are kinases that regulate the
assembly of the NOX2 oxidase complex by recruiting p47phox bound to p67phox and
p40phox; Akt, PKC and PKA negatively modulate NOX1 activity10. Unlike NOX1 and
NOX2, NOX4 exhibits constitutive activity. NOX4 agonists acutely increase its activity,
probably through the fast induction of protein expression, increasing the available NADPH
pool, or by promoting NOX4’s association with its receptors.10 The diverse range of
activators and repressors of NOX 1, 2 and 4 activity suggest that numerous upstream
mediators could be activated in response to SDF-1α. Therefore, further experiments are
needed to characterize the detailed molecular mechanisms by which NOX1, NOX2 and
NOX4 are activated by SDF-1α.
The downstream mediators of NOX1, NOX2, NOX4 and NOX5 responsible for promoting
the effects of SDF-1α-induced endothelial migration and angiogenesis are unknown. By
using NOX inhibitors and specific siRNAs of NOX5 and p22phox, we have demonstrated
that JNK3 and ERK are specific mediators for NOX5 in the regulation of SDF-1α-induced
angiogenesis (Figure 2, 3, SII, SIII). Moreover, we observed that the induction of HO-1, a
known mediator of SDF-1α-induced angiogenesis, is mediated by NOX5 (Figure SV).
However, whether JNK3 and ERK act as upstream mediators in response to SDF-1α to
induce HO-1 expression still needs further investigation. Other than the downstream
mediators that are mentioned above, multiple other pathways have been characterized as
downstream mediators of NOX1/2/4 in the regulation of cell proliferation and migration. For
example, Akt is reported to mediate NOX-promoted cell proliferation responses6, 45–47,
whereas the PPARα pathways have been implicated as downstream effectors for NOX1’s
effect on cell migration.48 The interaction of NOX2 and the scaffold protein IQGAP1 leads
to the accumulation of NOX2 at the leading edge of migrating endothelial cells49 and NOX4
is reported to regulate eNOS expression in endothelial cells.50 Whether these pathways are
involved in cell migration and proliferation associated with SDF-1α activation of these
NOXs still needs further investigation.
The data presented in this report is a continuation of our recent observations that JNK3 is a
major mediator of SDF-1α-dependent endothelial migration, and that MKP7, the JNK3
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phosphatase, is nitrosylated by nitric oxide and this nitrosylation leads to inhibition of its
phosphatase activity.18 Here, we present data demonstrating that MKP7 activity is also
inhibited by NOX inhibitors or NOX5 siRNAs, suggesting that the intracellular redox status
is critical for maintaining cellular functions for endothelial cells. Cysteine oxidation is one
important mechanism by which ROS modulate protein function and the oxidation of the
catalytic cysteine on MKP7 has been reported to be required for TNFα-induced JNK
activation.22, 51 Therefore, we propose that MKP7 is oxidized by NOX5-generated ROS
following SDF-1α administration, which in turn inhibits MKP7 phosphatase activity and
sustains JNK3 activation. All MKPs share this cysteine-containing catalytic motif,
suggesting they are similarly regulated by the intracellular redox status. In addition to
cysteine oxidation, other amino acids such as lysine, proline, arginine and threonine can also
be oxidized, and these modifications are recognized as being important for the pathogenesis
of many degenerative diseases.52 Future studies aimed at further characterizing the role of
protein oxidation may provide essential information that helps to explain the
pathophysiologic mechanism of oxidative stress.
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ROS reactive oxygen species
SDF-1α stromal cell-derived factor-1α
BAEC bovine aortic endothelial cell
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NOXs are well accepted as being novel players in the regulation of angiogenesis.
However, the underlying mechanisms by which they exert their actions have not been
completely elucidated. Using NOX inhibitors and NOX5-specific siRNA, our data
identify NOX5 as a novel component of SDF-1α-dependent JNK3 activation and support
the hypothesis that NOX-generated ROS are important mediators of SDF-1α-dependent
angiogenesis. More importantly, both nitrous and oxidative stresses, and therefore the
intracellular redox status, are important for SDF-1α-dependent signaling and endothelial
activation in response to pathophysiologic conditions such as hyperglycemia.
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ROS are generated following SDF-1α treatment. BAECs were treated with SDF-1α (100
ng/ml) for 5 minutes and ROS production was detected by CM-H2DCFDA (A-B) or DHE
staining (C-D). A, Representative images of DCFDA-stained cells. Scale bar, 10 µm. B,
Representative flow cytometry data obtained for H2O2 measurement that was detected as
green fluorescence after CM-H2DCFDA staining. This is an overlay picture of two samples-
the control (in blue) and 100 ng/ml SDF-1α-treated for 5 minutes (in gray). C–D, BAECs
were treated with SDF-1α in 100 ng/ml for different time periods (C) or different
concentrations for 5 minutes (D). O2·− production was quantified as ethidium bromide
fluorescence. *, P<0.05, compared to control BAECs. n=3. E, Representative images of an
endothelial cell monolayer with a scratch-wound. Cells were treated with SDF-1α (100
ng/ml) for 5 minutes and fixed for CM-H2DCFDA staining. Scale bar, 50 µm.
Pi et al. Page 16























NOXs inhibit SDF-1α-induced migratory and angiogenic responses in BAECs. A, A wound
healing assay was performed with BAECs. Cell monolayers were scratched, incubated with
NAC (10 mM) or ebselen (Ebs, 40 µM) for 30 minutes and then treated with SDF-1α (100
ng/ml). 24 hours later, cells were fixed and images were taken. The level of cell migration
into the scratch-wound was quantified as the recovered area. *, P<0.05, compared to control
cells; #, P<0.01, compared to control cells that were treated with SDF-1α. n=3. B, Boyden
chamber analysis of BAEC migration was performed using 100 ng/ml SDF-1α as the
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chemoattractant. *, P<0.001; compared to control cells without SDF-1α. #, P<0.001;
compared to control cells with SDF-1α. n=3. C, Boyden chamber analysis of BAEC
migration was performed using 100 ng/ml SDF-1α as the chemoattractant. BAECs were
transfected with p22phox, NOX5 or control siRNA. *, P<0.01; compared to control cells
without SDF-1α. #, P<0.01; compared to control cells with SDF-1α. n=3. D, In vitro
Matrigel angiogenesis assays were performed with BAECs that were transfected with
p22phox, NOX5 or control siRNAs. 100 ng/ml SDF-1α was used to induce tube formation.
Images of formed tubes were taken and tube numbers were counted. *, P<0.001; compared
to control cells without SDF-1α. #, P<0.05; compared to control cells with SDF-1α. Scale
bar, 50 µm.
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NOX5 is required for SDF-1α-induced JNK3 activation in BAECs. A, BAECs were
incubated with BHA (200 µM), NAC (10 mM) or ebselen (Ebs, 40 µM) for 30 minutes and
then treated with SDF-1α (100 ng/ml) for 10 minutes to activate JNK3. Cell lysates were
used for Western blotting to detect the activation of JNK3 using the phospho-JNK antibody.
The phosphorylation of JNK was interpreted as JNK3 phosphorylation since JNK3 is the
major JNK moiety activated by SDF-1α- in endothelial cells in our system.18 B, BAECs
were incubated with NOX inhibitors DPI (10 µM) or apocynin (Apo, 5 mM) for 30 minutes
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and then treated with SDF-1α (100 ng/ml) for 10 minutes to activate JNK3. Cell lysates
were used for Western blotting to detect the activation of JNK3. C, BAECs were transfected
with p22phox siRNA, NOX5 siRNA or control siRNA. Three days later, cells were treated
with SDF-1α (100 ng/ml) for 10 minutes to activate JNK3. Cell lysates were used for
Western blotting to detect the activation of JNK3. D, BAECs were transfected with Myc-
tagged NOX5 or control vector. Two days later, cells were treated with SDF-1α (100 ng/ml)
for 10 minutes to activate JNK3. Cell lysates were used for Western blotting to detect the
activation of JNK3. *, P<0.05; compared to control cells without SDF-1α; #, P<0.05;
compared to control cells with SDF-1α; n=3.
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The response to SDF-1α is blunted when BAECs were cultured in the presence of high
glucose concentrations. BAECs were cultured in media containing either normal glucose
concentration (7 mM glucose + 23 mM mannitol) or high glucose concentration (30 mM
glucose). Three days later, cells were incubated with ebselen (Ebs, 40 µM) for 30 minutes
and then treated with SDF-1α (100 ng/ml) for 5 minutes to determine ROS generation and
for 10 minutes to determine JNK3 activation. A, O2·− production was quantified as ethidium
bromide fluorescence. B, JNK3 activation was determined by Western blotting. *, P<0.05,
compared to control BAECs with low glucose and without SDF-1α. #, P<0.05; compared to
control cells without ebselen; NS, not significant; n=3.
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NOX5 is associated with MKP7. A, BAECs were transfected with Flag-MKP7 and GFP-
NOX5. Two days later, cells were fixed and analyzed by confocal microscopy. Scale bar,
5µm. B, A schematic representation of full length Flag-MKP7(1–665) and its deletion
mutant constructs. The black arrow indicates the fragment of MKP7 responsible for its
minimal association with NOX5. C, HEK293 cells were transfected with Flag-MKP7, Myc-
NOX5 or Myc-p22phox constructs. One day later, total cell lysates were used for
immunoprecipitation for Myc-NOX5 and Myc-p22phox, and immunoblotting for Flag-
MKP7. D, BAECs were treated with SDF-1α (100 ng/ml) for 5 minutes and harvested for
immunoprecipitation for NOX5 and immunoblotting for MKP7. TCL, total cell lysates. E,
The MKP7 proteins associated to NOX5 in BAECs were quantified as the fold change,
compared to the control cells. *, P<0.05; compared to control cells without SDF-1α; n=3. F,
HEK293 cells were transfected with different Flag-MKP7 mutants and Myc-NOX5
constructs. One day later, total cell lysates were used for immunoprecipitation for Myc-
NOX5 and immunoblotting for Flag-MKP7.
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MKP7 activity is regulated by NOX5. A, Results of an in vitro phosphatase assay using
active JNK3 protein as the substrate. BAECs were transfected with Flag- MKP7 and then
treated with DPI (10 µM) for 30 minutes and followed by SDF-1α (100 ng/ml) treatment for
5 minutes. The cell lysates concentrated for Flag-tagged MKP7 protein were used for in
vitro phosphatase assays. B, Quantitative analysis of results from in vitro phosphatase assays
of MKP7 in Figure 5A based on three independent experiments. *, P<0.05; compared to
control cells. NS, not significant. C, Results of an in vitro phosphatase assay using active
JNK3 protein as the substrate. BAECs were transfected with Flag-MKP7, and NOX5 or
control siRNA and then treated with SDF-1α for 5 minutes. The cell lysates concentrated for
Flag-tagged MKP7 protein were used for in vitro phosphatase assays. D, Quantitative
analysis of results from in vitro phosphatase assays of MKP7 in Figure 5C based on three
independent experiments. *, P<0.05; compared to control cells. NS, not significant.
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